ShangPharma opens pilot plant in Shanghai

Published: 17-Jan-2011
Design & Build Manufacturing Regulatory Research & Development Cleaning Analysis Pharmaceutical

For pharma development and cGMP manufacturing

ShangPharma Corporation, a China-based contract research and manufacturing organisation, has started operations at a new manufacturing facility in the Shanghai suburb of Fengxian.

The new multi-purpose pharmaceutical development and cGMP manufacturing facility will allow ShangPharma to support its clients Phase II and Phase III trials, expanding its service offering to include process and formulation r&d, analytical method development and validation, and cGMP manufacturing of intermediates and APIs.

Previously the CRO/CMO provided clients with materials for early discovery and GLP toxicology testing and Phase I clinical trials.

ShangPharma said it might further expand its manufacturing facilities if there is demand for commercial manufacturing of FDA- or EMEA-approved drugs.

The Fengxian facility will operate as a wholly owned subsidiary of the company under the name China Gateway Pharmaceutical Development Co. It includes a pilot plant that supports six separate bays with reactor capacities ranging from 200 to 3,000 litres and other speciality bays with reactor capacities ranging from 50 to 2000 litres for high temperature, cryogenics, highly toxic and pressurised reactions, including hydrogenation.

The company said there are also two cleanroom suites rated at Class 100,000 for isolation, 10 kilo-lab suites for bothnon-cGMP and cGMP manufacturing, as well as a large r&d laboratory for analytical, formulation and process development activities.

In addition, there are separate buildings for utilities, materials management, warehouse storage and waste water treatment with room for further expansion to support commercial manufacturing activities.

Testing of raw materials, intermediates and final products will be carried out at the site. An independent quality assurance department will ensure that materials are manufactured in accordance with cGMP requirements and that established standard operating procedures are followed, the firm said.

See more

You may also like

Hi Tech Manufacturing

Anxine responds to rising demand for integrated turnkey packaging solutions

Read more
Anxine has observed that more customers are moving away from purchasing individual machines and are instead choosing complete one-stop turnkey solutions that are easier to plan, manage, and put into operation

Trending Articles

  1. TCA takes full ownership of modular cleanroom range following joint launch in 2025 Total Clean Air has taken full ownership of the modular cleanroom brand, "Modular Clean Air", which was launched as a joint venture with Vanguard last year
  2. Pharmaceutical waste: What do I do with it? Emma Cooke from Envirovue discusses the many hazardous elements of pharmaceutical waste and the importance of effective management and compliance
  3. The Structural Nexus: Why Ceiling Systems are the Strategic Backbone of High-Performance Cleanrooms In the complex hierarchy of cleanroom construction, the ceiling is frequently relegated to the status of a finishing element. However, for those managing large-scale pharmaceutical or semiconductor builds, the ceiling is far from a mere lid. It is the primary structural nexus where architectural design, MEP integration, and life-safety systems converge
  4. Moderna reveals findings of vaccine contamination event A rare presence of Grade 316 stainless steel particles in the vaccine vials has been found but does not pose an undue risk to patient safety

Upcoming event

Cleanroom Technology Conference UK

20-21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Hi Tech Manufacturing

Anxine responds to rising demand for integrated turnkey packaging solutions

Anxine has observed that more customers are moving away from purchasing individual machines and are instead choosing complete one-stop turnkey solutions that are easier to plan, manage, and put into operation
Design & Build

TCA takes full ownership of modular cleanroom range following joint launch in 2025

Total Clean Air has taken full ownership of the modular cleanroom brand, "Modular Clean Air", which was launched as a joint venture with Vanguard last year
Design & Build

Built on precision: Airology celebrates 30 years of cleanroom innovation

Airology, a leading provider of advanced cleanroom and controlled environment solutions, proudly celebrates its 30th year in business. Over the past three decades, the company has grown from a specialist engineering firm into a trusted partner for organisations requiring high-performance, contamination-controlled environments
Pharmaceutical

Modular Devices wins Premier Inc agreement for pharmacy cleanroom solutions in the US

The healthcare improvement company Premier Inc has agreed a purchasing deal to expand access to US mobile and modular pharmacy cleanrooms
Containment

MBV conducts CFD analysis on automated settle plate changer

The Swiss-based company has conducted a CFD analysis on its MAS-100 Libra automated settle plate changer to determine backflow risk and VHP effectiveness
Pharmaceutical

Daiichi Sankyo – Cleanroom fit-out for the fill & finish area

At its Bavarian site in Pfaffenhofen an der Ilm, the pharmaceutical company Daiichi Sankyo is systematically expanding its production capacities for the sterile manufacturing and filling of medicinal products
Design & Build

CleanSpace Launches CleanSource, a U.S.-manufactured digital marketplace built on proprietary design and delivery expertise

Fort Washington, PA — April 21, 2026 — CleanSpace today announced the launch of CleanSource, an online sourcing platform engineered to transform how cleanroom and controlled environment products are sourced, specified, and delivered
Subscribe now